ZYTEK LABS HAIR GAIN

R 400.00

ZYTEK LABS HAIR GAIN(5MG FINASTERIDE/CAP=50CAPS)

DRUG CLASS: HORMONE INHIBITORS(ORAL) 

AVERAGE REPORTED DOSAGE: MEN 5 MG DAILY 

FINASTERIDE IS A DHT INHIBITOR. AN INHIBITOR USUALLY PREVENTS SOMETHING FROM BEING MANUFACTURED OR CONVERTED, RATHER THAN SIMPLY BLOCKING ITS RECEPTOR-SITES. IN THE CASE OF FINASTERIDE, THE DRUG INHIBITS 5-ALFA REDUCTASE ENZYME WHICH IS THE ENZYME RESPONSIBLE FOR TESTOSTERONE (NORTESTOSTERONE CONVERTS TO NOR-DHT) CONVERSION TO DHT (DIHYDROTESTOSTERONE). AS YOU KNOW BY NOW, DHT IS ONE OF THE HORMONES ASSOCIATED WITH ACCELERATED BALDING AND PROSTATE ENLARGEMENT. IT IS ALSO RESPONSIBLE FOR MANY OF THE VIRILIZING EFFECTS FROM ANDROGENIC STEROIDS. (LIKE IT ALSO HARDENS MUSCULATURE)

FINASTERIDE IS A PRESCRIPTION DRUG UTILIZED FOR PREVENTING HAIR LOSS. ABOUT 83% OF USERS REPORTED A HALT TO HAIR LOSS. UNFORTUNATELY, SOME ALSO REPORT A REDUCED LIBIDO TOO. (MOST SPORT WOODED IF THE WIND BLEW DURING AAS CYCLES). SINCE FINASTERIDE INHIBITS, OR ATLEAST REDUCES, THE CONVERSION OF TESTOSTERONES TO DHT, THEORETICALLY THERE WOULD BE A GREATER ANABOLIC EFFECT POSSIBLE DURING AAS CYCLES. BUT THERE WAS AN OBVIOUS LOSS OF HARDNESS TO THE PHYSIQUE REPORTED AS WELL.